Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RXDX

Prometheus Biosciences (RXDX) Stock Price, News & Analysis

Prometheus Biosciences logo

About Prometheus Biosciences Stock (NASDAQ:RXDX)

Advanced Chart

Key Stats

Today's Range
$199.92
$199.92
50-Day Range
$192.50
$199.92
52-Week Range
$23.27
$199.98
Volume
N/A
Average Volume
913,102 shs
Market Capitalization
$9.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RXDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prometheus Biosciences and its competitors with MarketBeat's FREE daily newsletter.

RXDX Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Prometheus Biosciences (NASDAQ: RXDX)
See More Headlines

RXDX Stock Analysis - Frequently Asked Questions

Prometheus Biosciences, Inc. (NASDAQ:RXDX) posted its earnings results on Tuesday, May, 9th. The biopharmaceutical company reported ($0.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.92) by $0.06. The firm's revenue was down 71.8% on a year-over-year basis.

Prometheus Biosciences subsidiaries include these companies: Prometheus Laboratories Inc..

Prometheus Biosciences (RXDX) raised $126 million in an IPO on Friday, March 12th 2021. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. SVB Leerink, Credit Suisse, Stifel and Guggenheim Securities served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prometheus Biosciences investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Netflix (NFLX), Visa (V) and Moderna (MRNA).

Company Calendar

Last Earnings
5/09/2023
Today
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:RXDX
Fax
N/A
Employees
97
Year Founded
1995

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$141.75 million
Net Margins
-3,768.76%
Pretax Margin
-3,768.76%

Debt

Sales & Book Value

Annual Sales
$6.81 million
Price / Cash Flow
N/A
Book Value
$16.12 per share
Price / Book
12.40

Miscellaneous

Free Float
46,187,000
Market Cap
$9.56 billion
Optionable
Not Optionable
Beta
-0.49

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:RXDX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners